Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Pediatrics and Neonatology
  • Pediatrics and Neonatology Guidelines
  • Atypical Bacterial...

Atypical Bacterial Pneumonia in Children: IAP Guidelines

Written By : Ayesha Sadaf |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-09-24T10:00:34+05:30  |  Updated On 24 Sept 2022 3:00 PM IST
Atypical Bacterial Pneumonia in Children: IAP Guidelines
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email
Community-acquired pneumonia (CAP) or infection of the lungs is a common cause of morbidity and mortality in children. In India, the typical organisms causing pneumonia are viruses [respiratory syncytial virus (RSV), human metapneumovirus (hMPV), influenza, and parainfluenza) and bacteria (gram-negative bacilli, Staphylococcus aureus, Streptococcus pneumoniae, and others). Pneumonia caused by atypical organisms (loosely referred to as "atypical pneumonia") may be caused by Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila.

The Indian Academy of Pediatrics (IAP) has released Standard Treatment Guidelines 2022 for Atypical Bacterial Pneumonia in Children. The lead author for these guidelines on Atypical Bacterial Pneumonia in Children is Dr. Joseph Mathew along with co-author Dr. B Antony Terance and Dr. Ritika Goyal. The guidelines come Under the Auspices of the IAP Action Plan 2022, and the members of the IAP Standard Treatment Guidelines Committee include Chairperson Remesh Kumar R, IAP Coordinator Vineet Saxena, National Coordinators SS Kamath, Vinod H Ratageri, Member Secretaries Krishna Mohan R, Vishnu Mohan PT and Members Santanu Deb, Surender Singh Bisht, Prashant Kariya, Narmada Ashok, Pawan Kalyan.

Following are the major recommendations of guidelines:

Epidemiology:

In general, M. pneumoniae and C. pneumoniae pneumonia are more common in children Epidemiology aged >3 years, Chlamydia trachomatis pneumonia is more frequent in infants, and L. pneumophila pneumonia is very rare in children aged <19 years.

As per a recent study from India, M. pneumoniae and C. pneumoniae serology was positive in 4.3% and 1.1% of CAP in children, respectively. Polymerase chain reaction (PCR)-based analyses of pneumonia etiology report prevalence <1%. L. pneumophila is relatively rare in children, accounting for <0.01% of pneumonia cases.

M. pneumoniae and C. pneumoniae are droplet infections caused by contact with an infected person. L. pneumophila spreads via aerosolization from humidifiers and hot water heaters. Human spread is not common.

Clinical Features:

  • Pneumonia and tracheobronchitis are the main manifestations of M. pneumoniae infection.
  • Children present with fever, malaise, sore throat, followed by cough that can last for 2–3 weeks.
  • Extrapulmonary disease can affect the skin, central nervous system (CNS), blood, heart, gastrointestinal tract, and joints.
  • Although, M. pneumoniae infection is self-limiting, it can lead to complicated pneumonia, parapneumonic effusions, necrotizing pneumonia, and bronchiolitis obliterans.
  • Radiological findings are consistent with bronchopneumonia involving the perihilar areas and lower lobes with hilar lymphadenopathy. The degree of consolidation in chest X-ray may be more than that expected for the severity of clinical manifestations.
  • C. pneumoniae and M. pneumoniae have similar clinical manifestations. Pneumonia is usually unilateral and involves the lower lobes.
  • Legionella presents with high-grade fever and productive cough, chest pain, and quickly progresses to alveolar disease with cavitation. It causes more extensive extrapulmonary organ dysfunctions such as dyselectrolytemia and renal failure, liver failure, and rhabdomyolysis.

Diagnosis:

  • PCR from an appropriate respiratory specimen is the best way of diagnosis. It should be remembered that nasopharyngeal specimens are only surrogates for appropriate specimens.
  • A four-fold or greater rise in Mycoplasma immunoglobulin M (IgM) titer in the convalescent versus acute period suggests acute infection. However, Mycoplasma IgM can remain positive for a year after infection, therefore, a combination of IgM and PCR may help differentiate carrier state from acute infection. Serology alone is not reliable for accurate diagnosis of Mycoplasma or Chlamydophila.
  • There is no standardized, validated test for diagnosis of Chlamydophila. As mentioned earlier, positive PCR can suggest Chlamydophila infection. Acute chlamydial infections are defined by a four-fold increase in the IgG titer or an IgM titer ≥16; and prior exposure is defined as an IgG titer ≥16
  • The most common method for Legionella detection is the urinary antigen assay.

Treatment:

  • Atypical pathogens do not have a peptidoglycan cell wall, hence they do not respond to β-lactam antibiotics. Instead, they show good responses to protein synthesis inhibitors (macrolides and tetracyclines) or deoxyribonucleic acid (DNA) synthesis inhibitors (fluoroquinolones).
  • Macrolides are the treatment of choice for atypical pneumonia because of their low minimum inhibitory concentration (MIC) and high safety profile in children. However, macrolide antibiotics should not be used indiscriminately and should be used only in confirmed Mycoplasma or Chlamydophila infections. This is especially true in settings where macrolides are reserved for multidrug-resistant Salmonella typhi infection.
  • There are reports of increasing incidence of macrolide-resistant M. pneumoniae pneumonia (MRMP) in some settings, although not in India. MRMP may be considered in patients with proven Mycoplasma pneumoniae who show no response to macrolide treatment for 72 hours.
  • Levofloxacin and doxycycline are alternative second-line antibiotics for MRMP and their use should be restricted because of the risk of side effects. Tetracycline can induce permanent teeth discoloration and there are reports of tendinopathy with fluoroquinolones.

TABLE 1: Treatment of atypical bacterial pneumonia.

Age group and pathogens

Empirical antibiotic

Comments

1–6 months

Chlamydia trachomatis

Azithromycin PO, 20 mg/kg once daily for 3 days

Conjunctivitis and staccato cough

≥6 months

Mycoplasma pneumoniae or Chlamydia pneumoniae

Azithromycin PO, 10 mg/ kg on day 1, followed by 5 mg/kg once daily from days 2–5

Alternative agents in case of macrolide resistance in an individual patient:

  • Levofloxacin
    • <5 years: PO/IV 8–10 mg/kg twice daily

- ≥5 years: PO/IV 10 mg/kg once daily

  • Doxycycline

- PO/IV 2.2 mg/kg every 12th hourly

Reference:

  • Basarab M, Macrae MB, Curtis CM. Atypical pneumonia. Curr Opin Pulm Med. 2014;20:247-51.
  • Kumar S. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric communityacquired lower respiratory tract infections. Indian J Med Res. 2018;147(1):23-31.
  • Mathew JL, Singhi S, Ray P, Hagel E, Saghafian-Hedengren S, Bansal A, et al. Etiology of community acquired pneumonia among children in India: prospective, cohort study. J Glob Health. 2015; 5(2):050418.
  • Phares CR, Wangroongsarb P, Chantra S, Paveenkitiporn W, Tondella ML, Benson RF, et al. Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand. Clin Infect Dis. 2007;45:e147-55.
  • Shim JY. Current perspectives on atypical pneumonia in children. Clin Exp Pediatr. 2020;63(12): 469-76.

The guidelines can be accessed on the official site of IAP: https://iapindia.org/standard-treatment-guidelines/

Indian Academy of PediatricIAP GuidelinesCAPRSVpneumoniahMPVinfluenzaChlamydophila
Source : Indian Academy of Pediatric, IAP Guidelines
Ayesha Sadaf
Ayesha Sadaf

    I have done my Bachelor of pharmacy from United Institute of Pharmacy and currently pursuing pharmaceutical MBA from Jamia hamdard. I worked as an intern at the position of content creator in Medical Dialogue and am highly obliged to the company for giving me this wonderful opportunity.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or...

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium Sulfide in Seborrheic Dermatitis Management

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium...

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic...

    View All

    Journal Club Today

    Rheumatoid Arthritis Cases Rise by 13 Percent Globally, Affecting Younger Populations: Study

    Rheumatoid Arthritis Cases Rise by 13 Percent Globally, Affecting Younger Populations: Study

    View All

    Health News Today

    Health Bulletin 18/June/2025

    Health Bulletin 18/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok